| P50 | author | Roger Y. Tsien | Q200470 |
| P2093 | author name string | Tao Jiang | |
| | Emilia S Olson | |
| | Todd A Aguilera | |
| | Margaret M Timmers | |
| P2860 | cites work | Treatment of terminal peritoneal carcinomatosis by a transducible p53-activating peptide | Q24796110 |
| | In vivo protein transduction: delivery of a biologically active protein into the mouse | Q29615482 |
| | Stromelysin-3 over-expression enhances tumourigenesis in MCF-7 and MDA-MB-231 breast cancer cell lines: involvement of the IGF-1 signalling pathway | Q33269607 |
| | Tumor imaging by means of proteolytic activation of cell-penetrating peptides | Q33569121 |
| | Transmembrane delivery of protein and peptide drugs by TAT-mediated transduction in the treatment of cancer | Q36049568 |
| | Present and future of cell-penetrating peptide mediated delivery systems: "is the Trojan horse too wild to go only to Troy?". | Q36306960 |
| | Cell penetrating peptides: intracellular pathways and pharmaceutical perspectives | Q36795351 |
| | Overcoming multidrug resistance of small-molecule therapeutics through conjugation with releasable octaarginine transporters | Q36858404 |
| | Tat peptide-mediated intracellular delivery of pharmaceutical nanocarriers | Q37021750 |
| | The design, synthesis, and evaluation of molecules that enable or enhance cellular uptake: peptoid molecular transporters | Q37278005 |
| | In vivo characterization of activatable cell penetrating peptides for targeting protease activity in cancer | Q39761175 |
| | Matrix metalloproteinase-activated doxorubicin prodrugs inhibit HT1080 xenograft growth better than doxorubicin with less toxicity. | Q40421746 |
| | Cell-penetrating peptides. A reevaluation of the mechanism of cellular uptake | Q40692947 |
| | Pharmacokinetics and delivery of tat and tat-protein conjugates to tissues in vivo | Q43804740 |
| | Is VP22 nuclear homing an artifact? | Q44166022 |
| | Role of membrane potential and hydrogen bonding in the mechanism of translocation of guanidinium-rich peptides into cells | Q45005329 |
| | Cellular internalization and distribution of arginine-rich peptides as a function of extracellular peptide concentration, serum, and plasma membrane associated proteoglycans | Q46758321 |
| | Novel Tat-Peptide Chelates for Direct Transduction of Technetium-99m and Rhenium into Human Cells for Imaging and Radiotherapy | Q64013814 |
| | Anti-cancer protein transduction strategies: reconstitution of p27 tumor suppressor function | Q73837083 |
| | A proapoptotic peptide for the treatment of solid tumors | Q77112307 |
| P433 | issue | 5-6 | |
| P304 | page(s) | 371-381 | |
| P577 | publication date | 2009-05-11 | |
| P1433 | published in | Integrative Biology | Q1524032 |
| P1476 | title | Systemic in vivo distribution of activatable cell penetrating peptides is superior to that of cell penetrating peptides | |
| P478 | volume | 1 | |